Introduction: The Connection Most Treatment Misses
People entering addiction treatment are almost universally asked what they are addicted to. They are far less commonly asked what happened to them.
This omission is not incidental. It reflects a treatment model that focuses on the substance — the drinking, the drug use, the behaviour — rather than the circumstances that made the substance necessary. And it is one of the primary reasons that so many people cycle through treatment without achieving lasting recovery.
The relationship between trauma and addiction is one of the most consistently demonstrated and most clinically significant findings in addiction medicine. It is not a niche observation or a contested theory. It is, in the words of Dr Gabor Maté — physician, addiction specialist, and author of In the Realm of Hungry Ghosts — the central clinical reality of addiction: “The question is not why the addiction, but why the pain.”
This article explains the trauma-addiction connection: the neuroscience, the epidemiology, and what it means for treatment. Understanding it changes both how addiction is seen and what effective recovery requires.
For the broader context on all the causes of addiction, read our pillar on why addiction happens: trauma, stress, and mental health. For more on how co-occurring mental health conditions intersect with substance use, see our resource on dual diagnosis and addiction recovery.
What Is Trauma?
Trauma is not simply a bad event. It is the psychological and neurobiological response to an experience — or pattern of experiences — that overwhelms the person’s capacity to cope and leaves lasting changes in how they experience themselves, others, and the world.
The Blue Knot Foundation, Australia’s national centre of excellence for complex trauma, identifies trauma as occurring when events are experienced as genuinely threatening to life, safety, or integrity — and when the person does not have sufficient internal or external resources to process the experience at the time it occurs.
Trauma takes several forms:
Acute trauma — a single, discrete event: an accident, an assault, a sudden bereavement, a medical emergency.
Complex or developmental trauma — repeated, prolonged, or cumulative experiences, typically occurring in childhood within caregiving relationships: emotional, physical, or sexual abuse; neglect; witnessing family violence; growing up with a parent who has a substance use disorder or mental illness; parental separation under distressing circumstances; or severe and sustained bullying.
Collective and cultural trauma — experienced at the community or population level: forced displacement, intergenerational trauma, discrimination, or the impacts of colonisation. For Aboriginal and Torres Strait Islander peoples in Australia, the ongoing effects of historical and intergenerational trauma are among the most significant and underaddressed clinical issues in the AOD treatment system.
It is complex and developmental trauma — the kind that accumulates across childhood, within the relationships that were supposed to be safe — that carries the strongest statistical relationship with addiction.
The Evidence: How Strong Is the Trauma-Addiction Connection?
The most compelling epidemiological evidence for the trauma-addiction link comes from the Adverse Childhood Experiences (ACE) Study — a landmark investigation conducted by the Centers for Disease Control and Prevention and Kaiser Permanente, involving more than 17,000 adults across multiple survey waves.
The ACE Study assessed exposure to ten categories of childhood adversity: physical, emotional, and sexual abuse; physical and emotional neglect; and five forms of household dysfunction including witnessing domestic violence, living with a substance-using family member, parental mental illness, parental separation, and an incarcerated household member.
The findings established dose-response relationships between ACE scores and health outcomes across virtually every major disease category. For substance use disorders specifically:
- Each additional ACE category was associated with a two- to fourfold increase in the likelihood of alcohol or drug problems
- People with four or more ACEs had a 700% greater likelihood of alcoholism compared to those with no ACEs
- People with five or more ACEs were 7 to 10 times more likely to report illicit drug use
- The relationship held across gender, ethnicity, education level, and socioeconomic status
These are not modest associations. They are among the largest effect sizes in chronic disease epidemiology — and they provide a robust empirical answer to the question of why some people develop addiction while others using the same substances do not.
In the Australian context, the AIHW reports that trauma is present at very high rates in the AOD treatment population, with particular concentration in populations already experiencing multiple disadvantage: people experiencing homelessness, those involved in the criminal justice system, people who have experienced family violence, and Aboriginal and Torres Strait Islander peoples, among whom the intergenerational impacts of colonisation and the associated trauma are a significant and unresolved clinical and social issue.
The Neuroscience: How Trauma Drives Substance Use
The statistical relationship between trauma and addiction is explained, at the neurobiological level, by what trauma does to the brain — particularly the developing brain of a child.
The Stress Response System
Trauma activates the brain’s stress response — the hypothalamic-pituitary-adrenal (HPA) axis and the associated release of cortisol and adrenaline. In a healthy stress response, these neurochemical changes are time-limited: they mobilise the person to respond to the threat, and then return to baseline when the threat passes.
When trauma is chronic, repeated, or overwhelming, this return to baseline does not fully occur. The HPA axis becomes dysregulated — persistently activated at a low level, with lower thresholds for activation and impaired capacity to return to calm. The amygdala (the brain’s threat-detection centre) becomes hypersensitised. The prefrontal cortex — responsible for regulating the amygdala, for planning, impulse control, and rational decision-making — becomes relatively less effective.
The result is a nervous system that operates in a chronic low-level state of threat: hypervigilant, emotionally reactive, with a narrow window of tolerance and limited access to the reflective, frontal-cortex-mediated capacity for self-regulation.
How Substances Provide Relief
Into this neurobiological context, substances arrive as relief. Not metaphorically — neurochemically.
Alcohol suppresses the central nervous system, reduces amygdala reactivity, and quiets the hypervigilant threat-detection system. For someone whose nervous system is chronically activated, the subjective experience is not just relaxation. It is the first moment of genuine calm they have felt since before they can remember.
Opioids activate the brain’s endogenous opioid system — the same system involved in social bonding, pain relief, and the sense of being safe and connected. For someone whose early attachment experiences were characterised by danger rather than safety, opioids provide a neurochemical simulation of the felt sense of security that was never adequately established in development.
Cannabis reduces anxiety and blunts emotional reactivity. For someone with chronic PTSD symptoms, it quiets the intrusive re-experiencing and the hypervigilance — at a cost, over time, to mood, motivation, and cognitive function.
Stimulants activate dopamine systems, producing confidence, social ease, and a sense of capacity. For someone whose trauma has left them with chronic shame, depression, and a felt sense of inadequacy, stimulants provide a temporary neurochemical override of these states.
In each case, the substance works. That is the point. It addresses a genuine, neurobiologically rooted suffering — inadequately and at increasing cost over time, but genuinely. Understanding this is foundational to both compassion for people with addiction and effective clinical treatment.
PTSD and Substance Use Disorder: A Special Relationship
Post-Traumatic Stress Disorder (PTSD) and substance use disorder co-occur at particularly high rates. Research published in the Australian and New Zealand Journal of Psychiatry found that among Australians with lifetime PTSD, rates of alcohol use disorder were approximately three times higher than in the general population, with similar elevations for other substance use disorders.
The relationship is bidirectional and mutually reinforcing:
PTSD drives substance use — Alcohol and drugs are used to manage PTSD symptoms: to numb intrusive memories and flashbacks, quiet hypervigilance and exaggerated startle responses, and find the sleep that PTSD-related hyperarousal prevents.
Substance use worsens PTSD — Alcohol suppresses REM sleep, disrupting the natural overnight consolidation and processing of emotional memory that is one of the brain’s primary mechanisms for processing trauma. Chronic substance use also impairs the prefrontal cortex function required for the emotional regulation and distress tolerance that recovery from PTSD requires.
Withdrawal reactivates PTSD symptoms — Anxiety, hypervigilance, sleep disruption, and emotional reactivity — all characteristic of both PTSD and substance withdrawal — overlap and reinforce each other during early sobriety. For many people, withdrawal feels like a reactivation of the trauma state, creating powerful pressure to return to use.
This cycle — PTSD → substance use → PTSD worsening → withdrawal mimicking PTSD → return to use — is one of the most common and most clinically entrenched patterns in the AOD treatment population.
What Trauma-Informed Addiction Treatment Looks Like
Understanding the trauma-addiction link has direct clinical implications for what effective treatment must include. Treating addiction without addressing underlying trauma is like treating infection without addressing the immune deficiency driving it — symptoms may reduce temporarily, but the underlying vulnerability remains and drives relapse.
Safety First
Trauma-informed care begins with safety — not as a therapeutic technique, but as a foundational operational principle. Before any meaningful therapeutic engagement can occur, the person must experience the treatment environment as genuinely safe: physically, relationally, and emotionally.
This is why the physical environment of treatment matters clinically. A chaotic, institutional, overcrowded, or threatening environment reactivates the very nervous system states that trauma produced — making deep therapeutic engagement impossible regardless of the clinical quality of the therapy being offered.
Stabilisation Before Processing
The sequencing of trauma work in addiction treatment is clinically important. Trauma processing — working directly with traumatic memories and their emotional content — before the person has adequate emotional regulation skills and sufficient nervous system stability can destabilise rather than heal.
Effective trauma-informed AOD treatment follows a phase-based model:
Phase 1 — Safety and stabilisation: establishing the therapeutic relationship, building emotional regulation skills (DBT distress tolerance, grounding techniques, breathwork), and creating the internal and external conditions for the deeper work.
Phase 2 — Trauma processing: when stabilisation is established, working with the traumatic material itself — through evidence-based trauma therapies including trauma-focused CBT, EMDR (Eye Movement Desensitisation and Reprocessing), somatic approaches, or narrative therapy.
Phase 3 — Integration: consolidating the changes, building the sense of a coherent personal narrative that integrates the trauma experience without being defined by it, and anchoring the new self-understanding in values, purpose, and forward direction.
The Role of the Trauma Specialist Psychologist
Not all AOD counsellors are trained in trauma therapy. The clinical skills required for safe and effective trauma processing — the ability to titrate exposure, track nervous system activation, maintain the therapeutic window, and respond to trauma activation in real time — are specialised and distinct from general addiction counselling competencies.
At HARP, the Trauma Specialist Psychologist operates as a dedicated pillar of the clinical team — distinct from the Addiction Specialist and the AOD Counsellor — precisely because the trauma work that underlies most presentations requires this level of specialisation. The three roles operate as an integrated team: the Addiction Specialist addresses the neurobiological and behavioural dimensions; the Trauma Specialist Psychologist addresses the emotional and somatic roots; the AOD Specialist provides substance-specific clinical intervention. Together, they address the full architecture of addiction and trauma simultaneously — not sequentially or through referral.
HARP’s residential programme integrates trauma-informed care as a central clinical pillar — not an optional additional service. The Interest module of the 5i Recovery Curriculum addresses trauma awareness, somatic regulation, inner child work, attachment repair, and fight/flight/freeze/fawn tracking as core programme content. For more on the curriculum, read the 5i Curriculum explained.
What Good Trauma-Informed AOD Treatment Avoids
A programme claiming to be trauma-informed must demonstrate more than awareness that trauma exists. Specific clinical practices that harm rather than help are well-documented in the literature:
Confrontational approaches — Models that rely on breaking down defences through confrontation (historically common in some 12-Step facilitation models) are contraindicated for trauma survivors, whose defences are adaptive responses to genuine threat rather than evidence of denial requiring dismantling.
Forced disclosure — Requiring clients to share traumatic material in group settings before adequate safety and stabilisation is established can re-traumatise rather than heal.
Shame-based intervention — For a population in which shame is already one of the most powerful drivers of continued use, approaches that increase shame without building the self-compassion and regulatory capacity to manage it worsen outcomes.
Premature discharge — Trauma processing creates a period of increased vulnerability. Discharging clients from residential care before adequate stabilisation and integration undermines the work done and elevates relapse risk.
Frequently Asked Questions
Can addiction be caused entirely by trauma? Trauma is one of the most significant risk factors for addiction — but not the only one. The biopsychosocial model identifies the intersection of biological vulnerability (genetics, neurobiology), psychological factors (trauma, mental health, emotional regulation capacity), and social and environmental factors (family history, peer norms, access to substances, socioeconomic circumstances) as the causes of addiction. Trauma substantially elevates risk, but addiction can develop in the absence of identifiable trauma, and trauma does not inevitably produce addiction.
Can you recover from addiction without addressing trauma? Some people do — particularly where addiction is mild to moderate, the trauma history is less complex, or sufficient time and natural healing have occurred. For the majority of people with moderate to severe addiction and significant trauma histories, however, the evidence strongly supports the position that sustained recovery requires addressing the trauma driving the use. Programmes that do not integrate trauma-informed approaches see higher rates of relapse, particularly in the first year after treatment.
What is the difference between trauma-informed care and trauma therapy? Trauma-informed care describes an organisational philosophy and set of operational principles — prioritising safety, trustworthiness, peer support, collaboration, empowerment, and cultural humility across all aspects of a service. Trauma therapy refers to specific clinical interventions that directly target traumatic memory and its effects — including trauma-focused CBT, EMDR, somatic experiencing, and others. Effective addiction treatment integrates both: an organisationally trauma-informed environment and specific clinical trauma therapies delivered by appropriately trained practitioners.
How does EMDR work for addiction and trauma? EMDR (Eye Movement Desensitisation and Reprocessing) is a structured evidence-based trauma therapy recommended by the World Health Organization and the Australian Psychological Society for PTSD. It works by activating bilateral brain stimulation (typically through guided eye movements) while the person holds elements of the traumatic memory in mind — a process that appears to facilitate the natural information processing the brain uses during REM sleep, allowing traumatic memories to be processed and integrated rather than stored in the fragmented, overwhelmingly present form characteristic of PTSD. In addiction contexts, EMDR addresses the traumatic memories and beliefs that drive substance use and relapse behaviour.
Sources
- Felitti VJ et al. — “Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the ACE Study,” American Journal of Preventive Medicine (1998)
- Blue Knot Foundation — Understanding Complex Trauma
- AIHW — Alcohol and Other Drug Treatment Services in Australia, 2022–23
- Mills KL et al. — “PTSD and substance use disorders among people with traumatic experiences,” Australian and New Zealand Journal of Psychiatry (2006)
- Maté G — In the Realm of Hungry Ghosts: Close Encounters With Addiction (2008)
- SAMHSA — Trauma-Informed Approach and Trauma-Specific Interventions
- World Health Organization (WHO) — EMDR for PTSD
- Australian Psychological Society (APS) — Evidence-Based Treatments for PTSD
- HARP — Dual Diagnosis and Addiction Recovery
- National Alcohol and Other Drug Hotline — 1800 250 015 (free, confidential, 24/7)
This article is reviewed for clinical accuracy and is intended for educational purposes only. It does not constitute medical advice. Please consult your GP, a registered psychologist, or a qualified AOD specialist for personalised guidance.
